D Bunjes1. Show Affiliations » 1. Stem Cell Transplantation Programme, Department of Haematology/Oncology, Ulm University Hospital, Robert-Koch-Strasse 8, 89081, Ulm, Germany. donald.bunjes@medizin.uni-ulm.de
Abstract
Entities: Gene
Mesh： See more » Acute DiseaseAlemtuzumabAntibodies, Monoclonal/immunologyAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/immunologyAntigens, CD/immunologyAntigens, NeoplasmBone Marrow TransplantationCD52 AntigenClinical Trials as TopicGlycoproteins/immunologyGraft RejectionGraft SurvivalGraft vs Host Disease/epidemiologyGraft vs Host Disease/etiologyGraft vs Host Disease/prevention & controlHematopoietic Stem Cell Transplantation/adverse effectsHematopoietic Stem Cell Transplantation/methodsHumansIncidenceLeukemia/therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/therapyLymphocyte DepletionRecurrenceRemission InductionRetrospective StudiesSafetySalvage TherapyT-Lymphocytes, Cytotoxic/immunologyTransplantation ConditioningTransplantation, HomologousTreatment Outcome
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, CDAntigens, NeoplasmCD52 AntigenCD52 protein, humanGlycoproteinsAlemtuzumab
Year: 2000 PMID： 11035276 DOI： 10.1016/s0955-3886(00)00079-5
Source DB: PubMed Journal: Transfus Sci ISSN： 0955-3886